KPX Lifescience.Co.Ltd (114450) — Cash Flow Quality Index
KPX Lifescience.Co.Ltd (114450) has a Cash Flow Quality Index of 6.79x as of September 2025. Operating cash flow of ₩3.33 Billion exceeds net income of ₩490.19 Million, indicating high earnings quality where cash backs reported profits. Explore KPX Lifescience.Co.Ltd strategic investment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
KPX Lifescience.Co.Ltd Cash Flow Quality Index (2015–2024)
Historical Cash Flow Quality Index for KPX Lifescience.Co.Ltd across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check KPX Lifescience.Co.Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for KPX Lifescience.Co.Ltd (2015–2024)
Year-by-year earnings quality comparison for KPX Lifescience.Co.Ltd. For live market cap and the full company financial profile, see KPX Lifescience.Co.Ltd market cap and net worth.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.34x | ₩525.49 Million | ₩1.56 Billion | ▼ -90.5% |
| 2019 | 3.55x | ₩4.24 Billion | ₩1.20 Billion | ▲ +38.9% |
| 2017 | 2.55x | ₩5.68 Billion | ₩2.22 Billion | ▲ +62.8% |
| 2016 | 1.57x | ₩7.07 Billion | ₩4.50 Billion | ▲ +50.5% |
| 2015 | 1.04x | ₩5.62 Billion | ₩5.39 Billion | — |